# Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain

> **NCT01863810** · PHASE3 · UNKNOWN · sponsor: **KunWha Pharmaceutical Co., Ltd.** · enrollment: 394 (estimated)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DRUG:** KW21052
- **DRUG:** Lyrica
- **DRUG:** Lyrica (low dose)
- **DRUG:** Placebo of KW21052
- **DRUG:** Placebo of Lyrica

## Key facts

- **NCT ID:** NCT01863810
- **Lead sponsor:** KunWha Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 394 (ESTIMATED)
- **Last updated:** 2013-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01863810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01863810, "Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01863810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*